Always confirm with your physician
These thresholds were determined in p53-null parental cell lines CAOV3, SKOV3, and OVCAR5, and IC 50 values were 27, 43, and 49 M, respectively (Fig
When choosing among them, factors such as glycemic efficacy, weight effects and patient preferences may take precedence over concerns about major differences in [GI] risk. She added clinicians should continue to monitor for GI symptoms, particularly early in treatment, as these events, while uncommon, remain more frequent than with some other diabetes drug classes. According to Alkabbani and colleagues, recent trials revealed that dulaglutide (Trulicity, Eli Lilly), semaglutide (Ozempic/Wegovy, Novo Nordisk) and tirzepatide (Zepbound, Eli Lilly) increased the risk for mild to serious GI adverse events like pancreatitis, constipation, nausea, vomiting and biliary disease
In addition, labile iron pools can catalyze lipid radical propagation through Fenton-type reactions, further amplifying membrane lipid peroxidation [71, 72]